Next Generation Multi-Omics & Biomarker Profiling

AI Analysis of tissue images

What we do

EquaPathAI provides rapid, AI-driven molecular insight from patient tissue images — turning ordinary H&E slides into rich, explainable biomarkers.

Our platform allows hospitals and academic labs worldwide to upload pathology data securely for low-cost, high-accuracy analysis, powered by partners such as PredxBio.

We deliver results in minutes rather than days, helping clinicians detect subtle tumor and immune patterns that traditional methods overlook.

By democratizing access to computational pathology, EquaPathAI bridges the gap between advanced diagnostics and under-resourced regions. Our mission is simple yet transformative — to make AI-powered precision pathology available to every lab, everywhere. 

What we do

Who do we serve?

Hospitals

Hospitals & Labs

EquaPathAI empowers hospitals and diagnostic laboratories to accelerate pathology workflows with AI-driven tissue analysis. By transforming standard H&E slides into molecularly rich data within minutes, EquaPathAI helps clinicians uncover subtle tumor and immune features that guide more precise treatment decisions. Our secure, cloud-based platform reduces dependency on costly molecular assays, improves turnaround time, and enhances diagnostic confidence — delivering faster, data-driven insights for better patient outcomes.

Clinical Products

  • EquaPathAI delivers AI-powered pathology insights directly from standard H&E slides — transforming diagnostics for hospitals and research labs worldwide.

  • Receive deep biomarker insights in minutes, not days — no extra tests or instruments needed.

  • Reduce costs and expand access by turning existing slides into molecular-level data through secure, cloud-based AI.

    •  
Research

Research

For academic and translational researchers, EquaPathAI provides a scalable platform for computational pathology and biomarker discovery. We enable AI-powered quantification of spatial patterns, cell states, and microenvironmental features from digitized slides — accelerating discovery while lowering experimental costs. By integrating AI, pathology, and data science, EquaPathAI supports large-scale studies, multi-center collaborations, and the next generation of research in precision oncology and spatial biology. 

Research Products

  • EquaPathAI empowers researchers to accelerate discovery by unlocking molecular and spatial insights directly from H&E slides.

  • Analyze tumor–immune architecture and spatial biomarkers using explainable AI — at a fraction of traditional costs.

  • Scale studies globally with a cloud-based platform built for collaboration, reproducibility, and data integrity. 

Technology – AI-driven analysis

EquaPathAI’s AI platform—developed with experts at UPMC and PredxBio—transforms standard H&E slides into diagnostic-grade insights in minutes.

Built for trust and transparency, it explains its predictions, revealing the biology behind every result.

Designed for clinical safety and rapid validation, EquaPathAI brings research-grade innovation directly into hospital workflows, empowering clinicians to see what others miss—anywhere, anytime.

About EquaPathAI

EquaPathAI empowers clinicians and researchers to see what others miss — anywhere, anytime.
By transforming standard H&E slides into molecularly rich, AI-driven insights, PathoLink makes precision pathology faster, more affordable, and more accessible for every community.

It all begins with access
The story of PathoLink began with a simple question: What if advanced pathology could reach every corner of the world? After two years of research at UPMC Hillman Cancer Center, our founder saw firsthand how AI and digital pathology could uncover patterns invisible to the human eye — but also how many hospitals and labs lacked access to these transformative tools.

That experience led to the creation of EquaPathAI, a nonprofit initiative designed to democratize computational pathology. By partnering with PredxBio, we developed a secure, cloud-based platform that allows hospitals, academic labs, and clinicians to upload routine pathology images and receive AI-powered biomarker insights in minutes — not days. 

Our mission

EquaPathAI’s mission is to bridge the gap between advanced diagnostics and underserved regions by combining the power of AI, pathology, and global collaboration. We believe that cutting-edge analysis should not depend on geography or infrastructure. Every image holds potential — and every patient deserves the chance for early, precise diagnosis. 

Mission

Our vision

We envision a world where no lab is left behind — where every slide tells a deeper story, and where digital insight drives better treatment decisions, faster drug development, and more equitable healthcare outcomes worldwide. 

Vision

SIMPLE, TRANSPARENT, AND SCALABLE

Pricing

At EquaPathAI, we believe access to Al-powered patholgy houle affordable for every lab and research center-whether you're analyzing 10 slides or 10,000. Our pricing is designed to grow with your needs while supporting our mission to make advanced diagnostics available globaly.

Standard Analysis Plan

$100.00

per Image
(for the first 100 images)

  • Al-driven H&E analysis 

  • Explainable biomarker and spatial insights

  • Secure cloud-based upload and report delivery

  • 24-hour turnaround on most cases
Upload Now

Volume Discounts

Tier

Images per month

Cost per analysis

Starter

1-100

$100 per image

Growth

101-500

$85 per image

Advanced

501-1000

$70 per image

Enterprise

1000+

Upto 50% off


Academic & Nonprofit Partners
We offer special acadernic and global ncicin for universities, teaching hospitals, and research consortia.
Contact us to learn more about grant partnerships and subsidized access in underserved-regions.

Our Team

Reina Majumdar
Reina Majumdar
Founder

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis bibendum diam eu tellus cursus.

Dr Aman Khera
Dr Aman Khera
Pathologist

The analysis in done under the guidance of Dr Aman Khera, who is an esteemed pathologist based out of New Delhi, India.

Trusted by Leading Institutions

EquaPathAI was developed in collaboration with UPMC and PredxBio, combining world-class pathology expertise with cutting-edge AI to democratize access to molecular insights — anywhere in the world.

PredxBio

Contact Us

Email

We will reply as soon as possible

Send us an email

Phone

Mon - Fri 09:00 - 18:00

Call (800) 123 45 67

Regulatory Information
EquaPath AI ’s technologies and analytical tools are developed to advance research and innovation in computational pathology. Unless otherwise specified, all EquaPath AI products and services are intended for research use only and are not approved for diagnostic or clinical decision-making purposes.


© Copyright 2025 EquaPath AI - All Rights Reserved